ANTI-SARS-CoV-2 SEROCONVERSIO IN IMMUNE-MEDIATED KIDNEY DISEASES
Clinical trial NCT06753942 · COMPLETED
Trial details
- NCT number
- NCT06753942
- Sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-09-09
- Primary completion
- 2023-12-31
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.